SCHEMBL29344255

SCHEMBL29344255

Oc1cc2cccc(Br)c2c(Cl)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ INPPL1 O15357 1/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ IDO1 P14902 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ PLCG1 P19174 1/20 0.39
▸ TNNI3 P19429 1/20 0.39
▸ CCNA2 P20248 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29937317 1.00 MEN1 (0.39) MEN1ALDH1A1KMT2AKDM4EINPPL1
SCHEMBL25916103 0.71 ALDH1A1 (0.33) MEN1ALDH1A1KMT2ATP53HPGD
SCHEMBL29937420 0.71 CYP1A2 (0.39) MEN1ALDH1A1KMT2ACYP3A4GAA
SCHEMBL25323401 0.71 HSD17B10 (0.39) MEN1ALDH1A1KMT2AKDM4EINPPL1
SCHEMBL23043140 0.71 CYP1A2 (0.39) MEN1ALDH1A1KMT2ACYP3A4GAA
SCHEMBL28672182 0.69 PDPK1 (0.38) MEN1ALDH1A1KMT2AKDM4EINPPL1
SCHEMBL17744677 0.69 HPGD (0.32) ALDH1A1CYP3A4HPGDALOX15HSD17B10
SCHEMBL13853054 0.68 DAO (0.44) MEN1ALDH1A1KMT2AKDM4EINPPL1
SCHEMBL31049123 0.68 NQO2 (0.47) MEN1ALDH1A1KMT2AKDM4EINPPL1
SCHEMBL28736688 0.67 ALDH1A1 (0.43) MEN1ALDH1A1KMT2AKDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 — — US disclosed
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 — — US disclosed
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-18 — — US disclosed
EP-4322954-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT Merck Sharp & Dohme LLC (US) 2024-02-21 — — EP disclosed
WO-2022221739-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT MERCK SHARP & DOHME CORP. (US) 2022-10-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239788-A1 SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT KRAS, NRAS, HRAS MEN1 538/4885ALDH1A1 2871/4885KMT2A 1154/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback